Targeting of Extracellular Vesicle-Based Therapeutics to the Brain

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Neuroscience

Background:

• Extracellular vesicles (EVs) are natural nanoparticles with potential for drug delivery.
• EVs can overcome physiological barriers, including the blood-brain barrier (BBB).
• This capability is crucial for treating central nervous system (CNS) disorders.

Purpose of the Study:

• To review factors and techniques for successful brain targeting using EVs.
• To explore strategies for enhancing EV delivery to the brain.
• To discuss challenges and future directions in EV-based brain therapeutics.

Main Methods:

• Review of administration routes for EV delivery.
• Analysis of EV biological origins for targeting.
• Discussion of EV surface modification with ligands.
• Examination of large-scale EV production and drug loading.

Main Results:

• EVs offer a viable platform for crossing the BBB.
• Various strategies exist to enhance EV brain targeting.
• Challenges remain in scalable production and efficient drug loading.

Conclusions:

• EVs are promising for CNS drug delivery due to their BBB crossing ability.
• Optimizing administration routes, EV source, and surface modification are key.
• Addressing production and loading challenges will advance EV therapeutics for brain delivery.